Senate File 2119 H-8137 Amend the amendment, H-8118, to Senate File 2119, as passed 1 by the Senate, as follows: 2 1. Page 1, after line 7 by inserting: 3 < Sec. ___. NEW SECTION . 124.101C Injection drug use —— 4 legislative findings. 5 The general assembly of the state of Iowa finds and declares 6 the following: 7 1. Injection drug use is the main driver for increases in 8 hepatitis C cases among young adults due partially to recent 9 increases in the misuse of prescription and nonprescription 10 opioids as well as increases in opioid injections. 11 2. The number of patients diagnosed with opioid use disorder 12 increased three hundred seventy-eight percent from thirty-nine 13 thousand one hundred nine in 1999 to one hundred eighty-six 14 thousand nine hundred seventy-nine in 2013 in a seventeen-state 15 sample. 16 3. Opioid use disorder imposes considerable financial 17 burdens on state Medicaid programs, and the burden is 18 increasing over time. After adjusting for inflation, total 19 Medicaid costs associated with opioid use disorder more than 20 tripled over a five-year time period, reaching more than 21 three billion dollars in 2013, from nine hundred nineteen 22 million dollars in 1999, with most of the growth due to excess 23 nonopioid use disorder treatment costs for patients with opioid 24 use disorder, which increased three hundred sixty-three percent 25 over the period, triple the rate of growth in expenditures for 26 opioid use disorder treatment services. 27 4. Findings extrapolated to the entire United States 28 suggest that the Medicaid costs associated with opioid use 29 disorder increased from more than two billion dollars in 1999 30 to more than eight billion dollars in 2013, with the cumulative 31 costs over a fifteen-year time period amounting to more than 32 seventy-two billion four hundred million dollars. 33 5. The centers for disease control and prevention of 34 the United States department of health and human services 35 -1- H8118.3694 (3) 88 ss/rh 1/ 2 #1.
recommends that states scale up effective programs to promote 1 drug treatment as well as hepatitis testing and treatment 2 efforts in local communities. 3 6. Syringe services can be important in reducing the risk 4 of infection with blood-borne pathogens such as hepatitis 5 B and HIV, as well as hepatitis C, and should be part of a 6 comprehensive program that also addresses access to treatment, 7 medication-assisted treatment, and education of medical 8 professionals on the appropriate prescription of opioids. 9 7. Syringe services programs are a proven method of getting 10 people into substance use disorder treatment, with one study 11 finding that users of syringe services programs are five 12 times more likely to enter treatment than those who did not 13 participate. 14 8. The national academies of sciences, engineering, and 15 medicine recommends that states expand access to syringe 16 services programs combined with opioid agonist therapies in 17 accessible venues. > 18 ______________________________ ISENHART of Dubuque -2- H8118.3694 (3) 88 ss/rh 2/ 2